We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.98B
AUM Growth
+$132M
Cap. Flow
+$20.2M
Cap. Flow %
0.34%
Top 10 Hldgs %
41.51%
Holding
666
New
23
Increased
324
Reduced
223
Closed
42

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$142M
2
ASML icon
ASML
ASML
+$117M
3
TSEM icon
Tower Semiconductor
TSEM
+$112M
4
LRCX icon
Lam Research
LRCX
+$88M
5
MU icon
Micron Technology
MU
+$53.9M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$81.3M
2
LITE icon
Lumentum
LITE
+$72.3M
3
PM icon
Philip Morris
PM
+$40M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
META icon
Meta Platforms (Facebook)
META
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 54.47%
2 Communication Services 12.44%
3 Consumer Discretionary 11.77%
4 Consumer Staples 6.03%
5 Healthcare 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNSA icon
401
Kiniksa Pharmaceuticals
KNSA
$4.81B
$48.9K ﹤0.01%
1,015
+128
+14% +$5.67K
DELL icon
402
Dell
DELL
$288B
$48.6K ﹤0.01%
296
+219
+284% +$29.2K
ADMA icon
403
ADMA Biologics
ADMA
$1.96B
$48.2K ﹤0.01%
5,346
+670
+14% +$10.6K
MLYS icon
404
Mineralys Therapeutics
MLYS
$2.38B
$48.1K ﹤0.01%
1,777
+222
+14% +$6.51K
ALMS
405
Alumis Inc
ALMS
$3.74B
$48.1K ﹤0.01%
2,183
+273
+14% +$6.83K
KRC icon
406
Kilroy Realty
KRC
$4.52B
$47.9K ﹤0.01%
1,699
-160
-9% -$5.25K
ADPT icon
407
Adaptive Biotechnologies
ADPT
$3.46B
$47.6K ﹤0.01%
3,430
+432
+14% +$6.88K
WM icon
408
Waste Management
WM
$94.1B
$46K ﹤0.01%
200
-221
-52% -$50.8K
TYRA icon
409
Tyra Biosciences
TYRA
$1.87B
$45.9K ﹤0.01%
1,198
+150
+14% +$4.86K
SNDX icon
410
Syndax Pharmaceuticals
SNDX
$1.95B
$45.6K ﹤0.01%
1,952
+244
+14% +$5.3K
KOD icon
411
Kodiak Sciences
KOD
$2.64B
$45.4K ﹤0.01%
1,192
+150
+14% +$3.88K
RARE icon
412
Ultragenyx Pharmaceutical
RARE
$2.76B
$45.4K ﹤0.01%
2,166
+271
+14% +$6.1K
GRAL
413
GRAIL Inc
GRAL
$3.03B
$45.3K ﹤0.01%
876
+111
+15% +$8.6K
BCRX icon
414
BioCryst Pharmaceuticals
BCRX
$2.44B
$44.8K ﹤0.01%
4,708
+571
+14% +$4.43K
AGIO icon
415
Agios Pharmaceuticals
AGIO
$2.17B
$44.3K ﹤0.01%
1,310
+165
+14% +$4.68K
AUPH icon
416
Aurinia Pharmaceuticals
AUPH
$1.99B
$43.7K ﹤0.01%
2,947
+357
+14% +$5.22K
ZYME icon
417
Zymeworks
ZYME
$1.75B
$42.1K ﹤0.01%
1,681
+211
+14% +$4.99K
DFTX
418
Definium Therapeutics
DFTX
$5.83B
$41.8K ﹤0.01%
2,213
+278
+14% +$4.72K
STOK icon
419
Stoke Therapeutics
STOK
$1.78B
$41.8K ﹤0.01%
1,283
+162
+14% +$5.31K
NSA icon
420
National Storage Affiliates Trust
NSA
$3.37B
$41.7K ﹤0.01%
1,104
-104
-9% -$3.51K
LXP icon
421
LXP Industrial Trust
LXP
$3.6B
$41.4K ﹤0.01%
895
-87
-9% -$4.25K
PHVS icon
422
Pharvaris
PHVS
$2.41B
$40.7K ﹤0.01%
1,439
+181
+14% +$4.83K
OCUL icon
423
Ocular Therapeutix
OCUL
$1.9B
$40.5K ﹤0.01%
4,784
+599
+14% +$5.71K
SION
424
Sionna Therapeutics
SION
$2.04B
$40.2K ﹤0.01%
1,003
+127
+14% +$4.85K
SLG icon
425
SL Green Realty
SLG
$3.58B
$39.7K ﹤0.01%
1,075
-104
-9% -$4.33K
15 16
17
18 19

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, GF Fund Management held 666 positions worth $5.98B, up 2.3% from $5.85B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

GF Fund Management's Q1 2026 filing shows 23 new, 324 increased, 223 reduced and 42 closed positions. Its largest new stake was Coherent: 98,000 shares worth $23.3M. The largest sale was Sandisk, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 51% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q1 2026 buy was Coherent: 98,000 shares worth $23.3M.
  • GF Fund Management added most to Walmart Inc in Q1 2026, an estimated $142M increase.
  • GF Fund Management's biggest Q1 2026 reduction was Sandisk, cutting an estimated $81.3M.
  • GF Fund Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.4M.
  • GF Fund Management's ten largest holdings make up 42% of its $5.98B portfolio in Q1 2026.
  • GF Fund Management opened 23 new positions and closed 42 in Q1 2026.
  • GF Fund Management's portfolio value rose 2.3% quarter-over-quarter to $5.98B.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.